
Senores Pharmaceuticals Ltd Faces Mixed Technical Signals Amid Price Momentum Shift
2026-11-19 08:06:16Senores Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish trend to a sideways pattern. This change is underscored by a complex interplay of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, signalling a period of consolidation after recent volatility.
Read More
Senores Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-11-16 08:04:44Senores Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. Despite a recent dip in price, the stock’s technical indicators present a complex picture, with some metrics signalling caution while others suggest potential for moderate upside. Investors and analysts are closely monitoring these developments amid a backdrop of strong year-to-date returns and evolving market dynamics.
Read More
Senores Pharmaceuticals Ltd is Rated Hold by MarketsMOJO
2026-11-09 10:10:56Senores Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 September 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 November 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall market standing.
Read MoreSenores Pharmaceuticals Gains 2.24%: 3 Key Factors Driving the Week’s Momentum
2026-11-07 10:02:14Key Events This Week 2 Nov: Valuation adjusted amid price correction and peer comparison 3 Nov: Technical momentum shifts amid mixed indicator signals 4 Nov: Technical momentum shifts to mildly bullish stance 6 Nov: Week closes at ₹1,158.95 (+2.24%) Week Open₹1,133.60 Week Close₹1,158.95<...
Read More
Senores Pharmaceuticals Ltd Hits Intraday Low Amid Price Pressure
2026-10-30 09:57:21Senores Pharmaceuticals Ltd experienced significant intraday weakness on 30 Oct 2026, with its stock price touching a low of Rs 1,077.6, marking an 11.57% decline from previous levels. The stock underperformed its sector and broader market indices, reflecting immediate selling pressure and subdued market sentiment.
Read More
Senores Pharmaceuticals Ltd Hits Intraday Low Amid Price Pressure
2026-10-29 15:02:07Senores Pharmaceuticals Ltd experienced a significant intraday decline on 29 Oct 2026, with its stock price touching a low of Rs 1,215, marking an 8.24% drop. This downturn contrasts sharply with the broader market’s positive momentum, reflecting immediate pressures on the small-cap pharmaceutical firm.
Read More
Senores Pharmaceuticals Ltd is Rated Hold by MarketsMOJO
2026-10-27 10:10:57Senores Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 September 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 27 October 2026, providing investors with the latest insights into its performance and outlook.
Read More
Senores Pharmaceuticals Ltd is Rated Hold
2026-10-16 10:10:53Senores Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 September 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 16 October 2026, providing investors with an up-to-date view of the company's performance and outlook.
Read More
Senores Pharmaceuticals Ltd is Rated Hold
2026-10-05 10:10:36Senores Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 October 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read MoreShareholder Meeting / Postal Ballot-Scrutinizer"s Report
18-Nov-2026 | Source : BSESenores Pharmaceuticals Limited has informed the Exchange regarding the Scrutinizer Report dated November 17 2026
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
18-Nov-2026 | Source : BSESenores Pharmaceuticals Limited has informed the Exchange regarding Outcome of Postal Ballot
Regulation 30 Disclosure Regarding Issuance Of Certificate Of GMP Compliance By The State Service Of Ukraine On Medicines And Drugs Control
17-Nov-2026 | Source : BSEWe are pleased to announce that the manufacturing facility of our Subsidiary Company. Ratnatris Pharmaceuticals Private Limited has been awarded with the prestigious PIC/S GMP certification by the State service of Ukraine on Medicines and Drugs Control.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available